All In Biotech

Drug Trial Radar · NCT07181369

A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Tolerability, Pharmacokinetic, Pharmacodynamic, and Preliminary Efficacy Trial of GTX-B001 in Healthy Volunteers (Part A) and Patients With Chronic Inducible Urticaria (Part B)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

72

Planned (sponsor's estimate)

Start

Oct 6, 2025

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Granular Therapeutics LimitedIndustry
Sponsor type
Industry
First posted
Sep 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a first-in-human study aimed at determining the safety of a single dose of GTX-B001 in healthy participants and in people with chronic inducible urticaria.

Conditions

  • Healthy Subjects
  • Cold Urticaria
  • Symptomatic Dermographism
  • Chronic Inducible Urticaria

Interventions

  • GTX-B001Drug

    Single infusion of one of up to five dosages of GTX-B001

  • Normal SalineDrug

    Single infusion of normal saline

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety as assessed by the incidence and severity of adverse events (Parts A and B)Time frame: Day 1 to Day 85

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Charite Universitaetsmedizin Berlin

    Berlin, Germany · Recruiting

  • Charité Research Organization gmbh

    Berlin, Germany · Active not recruiting

  • Dermatologische Praxis

    Halle, Germany · Recruiting

  • Universitaetsklinikum Giessen und Marburg GmbH

    Marburg, Germany · Recruiting

  • Universitatsklinikum Münster

    Münster, Germany · Recruiting

  • Universitaetsklinikum Tübingen

    Tübingen, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.